LENZ Therapeutics, Inc.
NASDAQLENZ Therapeutics just absorbed one of the ugliest single-day drops of its life. The stock fell 21% on May 12 to $7.91. It followed a read-out event the day before that clearly failed to convince investors, and the Street responded with a flurry of target cuts that confirm the damage is fundamental, not technical. More than half the company's freely traded float is now held short…
Snapshot as of 28 Jun 2026
LENZ Therapeutics just absorbed one of the ugliest single-day drops of its life. The stock fell 21% on May 12 to $7.91. It followed a read-out event the day before that clearly failed to convince investors, and the…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for LENZ — free to start on ORTEX.
Sign up for free →Open LENZ on ORTEX